Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients with Locally Advanced Carcinoma of the Bladder

PURPOSE: This two-arm phase II multicenter trial was designed to assess the efficacy and toxicity of neoadjuvant paclitaxel, gemcitabine, and carboplatin (PCaG) in patients with invasive bladder cancer. METHODS: Patients in arm I had either clinical stage T2 with hydronephrosis or T3 bladder cancer....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Smith, David C., Mackler, Niklas J, Dunn, Rodney L., Hussain, Maha, Wood, David, Lee, Cheryl T., Sanda, Martin, Vaishampayan, Ulka, Petrylak, Daniel P., Quinn, David I., Beekman, Kathleen, Montie, James E.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716704/
https://ncbi.nlm.nih.gov/pubmed/18930256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2008.08.075
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items